CIK 0001618835 · Non-accelerated filer<br>Smaller reporting company
Evofem Biosciences, Inc.
Sign in to watch- Ticker
- EVFM
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 208527075
- Phone
- (858) 550-1900
- Business address
- 12400 HIGH BLUFF DRIVE, SUITE 600, SAN DIEGO, CA, 92130
- Former names
- Neothetics, Inc.
- 4 Open-market buy Chief Financial Officer bought 40,594 shares at $0.37 ($15,020)
- 4 Open-market buy Chief Executive Officer bought 135,000 shares at $0.38 ($50,625)
- 4 Shares withheld for taxes Chief Commercial Officer gave up 19,998 shares (to pay taxes)
- 4 Open-market buy Director bought 10,000 shares at $1.17 ($11,650)
- 4 Open-market buy Director bought 5,000 shares at $1.20 ($5,990)
- 4 Open-market buy Director bought 8,140 shares at $1.31 ($10,663)
- 4 Open-market buy Chief Commercial Officer bought 18,180 shares at $1.14 ($20,725)
- 4 Open-market buy Chief Financial Officer bought 24,500 shares at $1.03 ($25,235)
- 4 Open-market buy Chief Executive Officer bought 50,000 shares at $1.03 ($51,500)
- 4 Open-market buy General Counsel and Secretary bought 10,000 shares at $1.03 ($10,250)
- 4 Shares withheld for taxes General Counsel and Secretary gave up 42,120 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Commercial Officer gave up 31,480 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Medical Officer gave up 42,061 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Financial Officer gave up 42,280 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Executive Officer gave up 105,300 shares (to pay taxes)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 2 of 15 · 281 filings